Category Archives: Medical Devices
Republic of Georgia Contribution to Alleviant Medical Pivotal Study
Clinical Accelerator is very happy to highlight its continued contribution to Alleviant Medical’s ALLAY-HF Pivotal Study in the Republic of Georgia. The global ALLAY-HF Study is designed to demonstrate the safety and effectiveness of the Alleviant System – a no-implant … Continue reading
WhiteSwell Announces Six-Month Outcomes After eLym System Treatment for Acute Decompensated Heart Failure Patients in its DELTA-HF Study
Below, we are re-publishing with permission the press-release issued by WhiteSwell on March 06, 2024 Patients were rehospitalized for heart failure less frequently in the six months following therapy GALWAY, Ireland — 6 March 2024 — WhiteSwell, a company pioneering a new paradigm in the … Continue reading
BariaTek Medical Announces the First-in-Human Implantation of Its BariTon™ Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness
Below, we are re-publishing with permission the press-release issued by BariaTek Medical on February 06, 2024 PARIS–(BUSINESS WIRE)–BariaTek Medical, a privately held medical device company dedicated to the development of minimally invasive endoscopically delivered solutions to treat obesity and diabetes, … Continue reading
Laminar, Inc. Acquired by Johnson & Johnson Medtech for $400 Million Upfront with Additional Clinical and Regulatory Milestone Payments in 2024 and Beyond
Below, we are re-publishing with permission the press-release issued by Laminar, Inc. Santé Ventures was the sole venture capital investor in Laminar, which aims to treat persistent atrial fibrillation (AFib) with an innovative solution for the left atrial appendage (LAA) … Continue reading
Clinical Accelerator and Laminar Medical Announce Three-Year Milestone in Groundbreaking Collaboration for Atrial Fibrillation Treatment
Clinical Accelerator, a leading contract research organization (CRO) specialising in clinical trials with novel medical devices, and Laminar Medical, a pioneering medical device company developing a Left Atrial Appendage Closure System, are proud to celebrate a three-year milestone in their … Continue reading
Laguna Tech USA Announces Newly Designed Heart Valves with Advanced Engineering Successfully Implanted in First-in-Human Clinical Trial
Below, we are re-publishing with permission the press-release issued by Laguna Tech USA on October 24, 2023 IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions … Continue reading
Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation
Below, we are re-publishing with permission the press-release issued by Argá Medtech on Octobe 26, 2022 EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) — Argá Medtech announced today that it has begun enrollment in their First-in-Human Clinical Trial “Coherent Sine … Continue reading
Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat
Below, we are re-publishing with permission the press-release issued by Medcura, Inc. on January 12, 2023 January 12, 2023·3 min read COLLEGE PARK, Md., Jan. 12, 2023 /PRNewswire/ — Medcura, Inc., a medical device company dedicated to transformatively improving the management of … Continue reading
Clinical Accelerator announces collaboration with Airiver Medical on OXYGEN-1 trial : Safety and feasibility of Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a partnership with Airiver Medical, to evaluate the safety and efficacy of Airiver’s pulmonary Drug-Coated Balloon in the FIM treatment of benign Central Airway Stenosis. Central … Continue reading
Patient Enrollment Begins in Everolimus Drug-Coated Balloon Study
Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems Inc. on September 02, 2022 Cardiovascular Systems has an acquisition option agreement with the balloon’s developer, Chansu Vascular Technologies. Cardiovascular Systems Inc. (CSI) has begun enrolling patients in its … Continue reading
You must be logged in to post a comment.